News

Public · Published

Exicom Recalibrates Growth Trajectory on the Back of a Strong Q2; Doubles Down on EV Growth in India, Board Approves Tritium Divestment

Exicom reported second-quarter FY27 consolidated revenue of about ₹388 crore, up 38% sequentially, and positive EBITDA of about ₹2 crore. Its India standalone business recorded revenue of about ₹277 crore, up 21.3% year over year, including its first EV-charging quarter above ₹100 crore. The board approved a Tritium divestment.

Published:

Updated:

What happened

Exicom reported second-quarter FY27 consolidated revenue of about ₹388 crore, up 38% sequentially, and positive EBITDA of about ₹2 crore. Its India standalone business recorded revenue of about ₹277 crore, up 21.3% year over year, including its first EV-charging quarter above ₹100 crore. The board approved a Tritium divestment.

Confirmed

Global impact / market context

The results show stronger sales and a move to positive consolidated EBITDA, while losses narrowed year over year. The approved Tritium sale could reshape Exicom’s business mix; however, the supplied text says it retains a perpetual licence to TRI-FLEX technology, potentially preserving access to that technology.

Analyst inference

India standalone revenue growth and the record EV-charging quarter point to expanding business in Exicom’s home market. Consolidated results also include exports and Tritium, so the divestment may change how those sales and costs contribute to future reported performance.

Analyst inference

What to watch

  1. Look for details on the Tritium divestment, including its completion, proceeds and timing; the supplied text confirms board approval but gives no transaction terms. Analyst inference
  2. Track whether Exicom sustains India revenue growth and EV-charging sales above the reported record quarter, and whether EBITDA continues to improve. Analyst inference
  3. Watch for disclosure of how retaining a perpetual TRI-FLEX licence works after the Tritium sale, since the article gives no further terms. Analyst inference

Evidence

  • Original source link unavailable